logo
Market statusData NSENot investment advice
SHARDA CROPCHEM

SHARDA CROPCHEM Latest Share Price (SHARDACROP)

₹642.60
17.00−2.58%
Overall Score87/100
Day range631
₹642.60
664
52-week658
₹642.60
1,297
Above low-2.3%
Below high50.5%
Range position0%
Open662.00
Prev Close659.60
Bid642.57100
Ask642.63100

TODAY IN ONE LINE

SHARDACROP fell 2.6% on light volume, lagging Nifty's -0.4% move, hovering dangerously near its 52-week low.

With a market cap of ₹5,792.16 Cr., it trades at a P/E of 9.25. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.

Volume133.3K+54%vs 20D avg
Price Band20
Lower Band527.7
Upper Band791.5
Tick Size0.05
Daily Volatility3.07%
Annualised Vol58.65%
Market Cap₹5,792.16 Cr.
Promoter74.82%
Face Value₹10
Fwd P/E10.98
PEG0.45
EV/EBITDA6.78
P/S1.53
ROA8.51%
Beta1.16
Div Payout15.9%
THE STOCK SCORE
Overall Score87/100
Updated 07 Sept

How good is this company?

Overall performance across 5 key dimensions.

Each card tappable → shows formula + inputs
FLAGS & NEWS

SHARDA CROPCHEM flags & news 

Key strengths, potential risks, and recent updates.

✅ 10 green flags🚩 0 red flags

Green Flags

  • ●Earnings GrowthEPS (TTM) grew by a solid 56.5% YoY
  • ●High Capital EfficiencyROCE of 22.2% indicating pricing power
  • ●Strong Return on EquityHealthy ROE of 21.7%
  • ●Healthy Operating MarginsOPM is structurally strong at 16.3%
  • ●Reasonable ValuationTrading at a moderate P/E of 11.7x
  • ●High Promoter HoldingPromoters hold 74.8% skin-in-the-game
  • ●Steady Dividend YieldReliable 2.34% dividend yield
  • ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
  • ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
  • ●Zero Pledge RiskNo recent active promoter pledging found

Red Flags

No red flags identified

Latest SHARDA CROPCHEM News

THE CHANGELOG

What changed recently?

Recent events, corporate actions, and announcements.

No recent changes found for this period.
🔒Prime: full history + alerts on this stock
Valuation

SHARDA CROPCHEM valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for SHARDA CROPCHEM, framed against the sector median so the premium or discount is obvious at a glance.

SHARDA CROPCHEM trades at a P/E of 9.25× and P/B of 1.85×.

Key MetricsMarket + reported · 23 Oct 2026Consolidated

Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.

Valuation

Valuation

Market Cap
₹5,792.16 Cr.
P/E Ratio
9.25
P/B Ratio
1.85
EPS
₹9.76
Profitability

Profitability

ROE
21.71%
ROCE
22.19%
Net Margin
13.14%
Op Margin
16.27%
Growth

Growth

EPS YoY
56.5%
Revenue YoY
12.9%
Qtr Sales
—
Qtr Profit
—
Financial Health

Financial Health

Debt / Equity
—
Book Value
₹347.71
Div Yield
2.34%
Promoter Holding
74.82%
Technicals

SHARDA CROPCHEM technical analysis: indicators, pivots and CPR.

Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for SHARDA CROPCHEM — derived from the latest tape, not yesterday's close.

SHARDA CROPCHEM last traded at ₹642.6 with an intraday range of ₹631.35–₹664 — latest indicator, pivot and CPR signals below.

Last updated: 25 October 2026, 4:08 pm IST

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Last: ₹642.60
LevelPrice (₹)Distance% Δ
R4725.92+83.32+12.97%
R3693.27+50.67+7.88%
R2678.63+36.03+5.61%
R1660.62+18.02+2.80%
PIVOT645.983.380.53%
CURRENT642.60——
S1627.97-14.63-2.28%
S2613.33-29.27-4.55%
S3595.32-47.28-7.36%
S4562.67-79.93-12.44%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 644.29P: 645.98TC: 647.67
R1
R2
R3
R4
indicator
LTP: 642.60
PDH: 673.85
PDL: 658.00
● Market Sentiment

SHARDACROP is trading Below CPR, indicating Bearishness

● CPR Width

CPR is Wider, suggesting unlikely for trending moves

● Opening Range

Day's range: ₹647.15–₹664

● Price Position

Trading Below opening range, showing Bearishness

Financials

SHARDA CROPCHEM financials: P&L, balance sheet, cash flow, ratios.

Reported annual and quarterly results for SHARDA CROPCHEM — consolidated or standalone — with margins, YoY growth and key ratios inline.

SHARDA CROPCHEM reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹5,792.16 Cr. and reported EPS of ₹9.76.

iTap any row for a plain-English meaning▲▼Change vs a year ago — green means the move is healthy for that line, red means it isn’tDerivedCalculated by us, not reported directly
Mobile view
Latest vs previous year
MetricMar 2026May 2026
Revenue from Operations5,268
5,268
▲ 0.0%
Sales Growth YoY %Derived21.94%
21.94%
Other Income106
106
▲ 0.0%
Total Income5,373
5,373
▲ 0.0%
3,377
3,377
▲ 0.0%
Gross ProfitDerived1,890
1,890
▲ 0.0%
Gross Margin %Derived35.89%
35.89%
814
814
▲ 0.0%
EBITDA (Operating Profit)Derived1,076
1,076
▲ 0.0%
OPM %Derived20.43%
20.43%
326
326
▲ 0.0%
Profit Before Tax (PBT)856
856
▲ 0.0%
175
175
▲ 0.0%
Effective Tax %Derived20.40%
20.40%
Total Profit for Period681
681
▲ 0.0%
Less: Non-controlling Interests0
0
▲ 0.0%
Net Profit (Owner's PAT)Derived681
681
▲ 0.0%
Net Profit Margin %Derived12.93%
12.93%
PAT Growth YoY %Derived123.69%
123.69%
Earnings Per Share (EPS ₹)75.47
75.47
▲ 0.0%
Diluted Shares Outstanding (Cr)9
9
▲ 0.0%
Other Comprehensive Income (Net of Tax)63
63
▲ 0.0%
Total Expenses (incl. D&A & Interest)4,518
4,518
▲ 0.0%
Material Cost % of RevenueDerived42.31%
42.31%
Employee Cost % of RevenueDerived1.27%
1.27%
Other Cost % of RevenueDerived14.19%
14.19%
Interest Coverage (x)Derived427.86x
427.86x
Sales CAGR · 3Y
+6.8%
Sales CAGR · 5Y
+10.7%
PAT CAGR · 3Y
+30.8%
PAT CAGR · 5Y
+84.5%
all values in ₹ Cr unless marked % / x / ₹ · fiscal-period end shown · reported figures via Stockezee financials API · annual results may be audited; quarterly results may be unaudited or limited-review
Segment Analysis

SHARDA CROPCHEM segment analysis : revenue and profit mix.

Disclosed business segments at SHARDA CROPCHEM with their share of revenue and profit, switchable between consolidated and standalone reporting.

SHARDA CROPCHEM discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Thesis

The Bull, Bear, and Flip case for SHARDA CROPCHEM.

Our AI distills the core fundamental drivers supporting SHARDA CROPCHEM, the risks that threaten it, and the quantitative conditions that could weaken the thesis.

bull case

What you're getting.

No strengths or opportunities on record.

bear case

Key Risks.

No weaknesses or threats on record.

flip conditions

Flip Conditions.

  • Valuation risk. a P/E above 12 would leave less room for earnings disappointment.

  • Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.

  • Return-quality risk. ROE below 17% would indicate weaker capital compounding.

  • Income thesis breaks if the dividend is cut or yield falls below 1.17%.

Shareholding

SHARDA CROPCHEM shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in SHARDA CROPCHEM — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Annual • Sep 2026

Promoters74.82%
DII9.22%↑0.04%
FII3.27%↑0.16%
Public12.69%↓0.19%

Ownership Distribution

Promoters
74.82%
Domestic Institutions
9.22%
Foreign Institutions
3.27%
Retail & Public
12.69%

Category Trends

Foreign Institutions Breakdown
Total Holding: 3.27%
Net Change: +0.16%
Category Total3.27%
Total Holding3.27%
Net Change+0.16%
Not Fully Disclosed

⚠️Partial Disclosure Notice

Individual institutions below total 0.00%, but category aggregate is 3.27%. Some institutions may not be disclosed by the company as per regulatory requirements.

Institution Name
Trend (Last 6)
Holding %
QoQ Change
YoY ChangePeriod
PINEBRIDGE GLOBAL FUNDS - PINEBRIDGE INDIA EQUITY
0.00%
0.00%
0.00%
Sep 2026
PINEBRIDGE GLOBAL FUNDS- PINEBRIDGE INDIA EQUITY FUND
0.00%
0.00%
0.00%
Sep 2026
GOLDMAN SACHS INDIA LIMITED
0.00%
0.00%
0.00%
Sep 2026
PINEBRIDGE INVESTMENTS GF MAURITIUS LIMITED
0.00%
0.00%
0.00%
Sep 2026
Peers

SHARDA CROPCHEM peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — SHARDA CROPCHEM is highlighted for quick read-across.

09 · Chart Patterns

SHARDA CROPCHEM chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for SHARDA CROPCHEM — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

Delivery Conviction

SHARDA CROPCHEM delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for SHARDA CROPCHEM over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in SHARDA CROPCHEM stood at 51.5% of traded volume, against a 20-day average of 49.9%.

Avg Delivery (20D)49.9%+1.7 ppt latest vs avg
Highest Delivery59.9%on 19 Oct
Avg Volume (20D)86.7 K20-day run-rate
Conviction Trend↑ Strengthening+1.7 ppt latest read
Volume & Delivery · last 20 sessions
Exchange Filings & Investor Updates

SHARDA CROPCHEM announcements: results, concalls, ratings, M&A.

Filings SHARDA CROPCHEM sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

SHARDA CROPCHEM files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 109 documents below.

  1. 03 Oct 2026Certificate under SEBI (Depositories and Participants) Regulations, 2018View PDF

    Certificate under SEBI (Depositories and Participants) Regulations, 2018

    Sharda Cropchem Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  2. 28 Sept 2026Trading WindowView PDF

    Trading Window

    Sharda Cropchem Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,…

  3. 01 Sept 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Sharda Cropchem Limited has informed the Exchange about Schedule of meet

  4. 14 Aug 2026Shareholders meetingView PDF

    Shareholders meeting

    Sharda Cropchem Limited has informed the Exchange with copy of minutes of Annual General Meeting held on August 14, 2026

  5. 14 Aug 2026Shareholders meetingView PDF

    Shareholders meeting

    Sharda Cropchem Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 14, 2026. Further, the company…

Corporate Actions

SHARDA CROPCHEM dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue SHARDA CROPCHEM has declared, sequenced by announce and record date.

SHARDA CROPCHEM corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About SHARDA CROPCHEM: business, sector, key facts.

What SHARDA CROPCHEM does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

SHARDA CROPCHEM operates in the Pesticides & Agrochemicals industry under the Chemicals sector, listed as NSE: SHARDACROP, BSE: 538666.

SHARDACROP
Chemicals

SHARDA CROPCHEM

NSE · SHARDACROP·BSE · 538666·www.shardacropchem.com

Sharda Cropchem Limited is a multinational company primarily focused on the crop protection chemical industry. Its core business involves the research, development, manufacturing, and distribution of a wide range of agrochemical products designed to enhance crop yields and protect against pests and diseases. These products encompass insecticides, fungicides, herbicides, and plant growth regulators, catering to the diverse needs of global agricultural practices. They also offer a selection of veterinary drugs and biocides, further expanding their reach within related sectors.

Beyond agrochemicals, Sharda Cropchem boasts a significant industrial chemicals division. This segment provides a variety of organic and inorganic chemicals for use in diverse applications, including water treatment, food processing and the broader industrial sector. The company also manufactures and supplies dyes and dye intermediates, adding another layer to its industrial chemical portfolio. This diversification allows them to leverage their chemical expertise across multiple market segments.

A notable aspect of Sharda Cropchem's operations is its involvement in the manufacturing and distribution of conveyor belts. These belts are crucial components in various heavy industries, such as mining, steel production, cement manufacturing, and port operations. The company produces a range of conveyor belt types, tailored to meet the specific demands of different applications, including textile ply, steel cord, and PVC belts. Their offerings extend to other related products like cotton transmission belts and V-belts, solidifying their position as a significant player in the industrial supplies market.

Finally, Sharda Cropchem also engages in the supply and distribution of pharmaceutical and intermediate products. This area focuses on providing key components and materials utilized in the pharmaceutical industry. Examples of these include active pharmaceutical ingredients and precursor chemicals crucial for the production of various pharmaceuticals. This segment showcases the company's extensive network and expertise across diverse chemical-related fields. The company's history, beginning in 1987 and based in Mumbai, India, underscores its long-standing presence and expertise in the global chemical market.

company facts
Employees—
SectorChemicals
HeadquartersMumbai, India
Market Cap₹5,792.16 Cr.
Listed OnNSE
leadership17 on record
Mr. Amol Prabhughate
Manager of Human Resources
Mr. Ashish Bubna
Whole-time Director, Founder
Mr. Ashish Ramprakash Bubna
Founder & Whole-Time Director
Mr. H. S. Upendra Kamath
Non-Executive Independent Director
Mr. Jetkin Gudhka
Chief Compliance Officer, Company Secretary
Mr. Jetkin Navinchan Gudhka
Company Secretary & Compliance Officer
Mr. Manish Bubna
Whole-Time Director, Founder
Mr. Manish Ramprakash Bubna
Founder & Whole-Time Director
Mr. Ramprakash Bubna
Executive Chairman of the Board, Managing Director, Founder
Mr. Ramprakash Vilasrai Bubna
Founder, Chairman & MD
Mr. Shailesh Anant Mehendale
Chief Financial Officer
Mr. Shailesh Mehendale
Chief Financial Officer
§ ∞ · Plainly Answered

Questions investors ask about SHARDA CROPCHEM (SHARDACROP).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of SHARDA CROPCHEM (SHARDACROP)?

The current share price of SHARDA CROPCHEM (SHARDACROP) is ₹642.60. Today, the stock has declined by ₹17.00 (2.58%), trading in a range of ₹631.35 to ₹664.00. The stock opened at ₹662.00 with a trading volume of 1,33,271 shares.

02Is SHARDA CROPCHEM stock a good investment for long-term?

SHARDA CROPCHEM can be considered for long-term investment based on several factors. The company has a market capitalization of ₹5,792.16 Cr., P/E ratio of 9.25, ROE of 21.71%, and ROCE of 22.19%. The dividend yield stands at 2.34%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of SHARDA CROPCHEM stock?

The 52-week high price of SHARDA CROPCHEM (SHARDACROP) is ₹1,297.00, while the 52-week low is ₹658.00. Currently trading at ₹642.60, the stock is -2.34% above its 52-week low and 50.45% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy SHARDA CROPCHEM stock at the current price?

Whether to buy SHARDA CROPCHEM stock at ₹642.60 depends on multiple factors. The stock is currently trading with a P/E ratio of 9.25 and P/B ratio of 1.85. Today's performance shows a loss of 2.58%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of SHARDA CROPCHEM and when is the next dividend?

SHARDA CROPCHEM offers a dividend yield of 2.34%, which means for every ₹100 invested at the current price of ₹642.60, you can expect to receive approximately ₹2.34 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of SHARDA CROPCHEM?

SHARDA CROPCHEM's key financial metrics include: P/E Ratio: 9.25, P/B Ratio: 1.85, ROE: 21.71%, ROCE: 22.19%, Dividend Yield: 2.34%, EPS: ₹9.76, Book Value: ₹347.71, and Debt-to-Equity: 0. The company's market cap stands at ₹5,792.16 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is SHARDA CROPCHEM stock performing today in the market?

SHARDA CROPCHEM stock opened at ₹662.00 and is currently trading at ₹642.60, showing a decline of ₹17.00 (2.58%). The intraday high is ₹664.00 and low is ₹631.35. The trading volume stands at 1,33,271 shares, indicating moderate market participation today.

08What is the P/E ratio of SHARDA CROPCHEM and what does it indicate?

SHARDA CROPCHEM has a Price-to-Earnings (P/E) ratio of 9.25, which means investors are willing to pay 9.25 for every ₹1 of earnings. With an EPS of ₹9.76, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about SHARDA CROPCHEM (SHARDACROP) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.